Page 3 - Pharma Stocks
Cipla rallies 4%, hits 52-week high; Choice Broking sees more upside
Cipla stock outlook: A decisive breakout above ₹1,580 could trigger further upward momentum, paving the way towards the ₹1,770-₹1,850 target range in the medium term, said Choice Broking.
 "Cipla rallies 4%, hits 52-week high; Choice Broking sees more upside")
Divis Labs rallies 13% in 1 week; What's driving pharma stock?
Divis stock gained 2% in Monday's intra-day deals. Reports suggest the company is well positioned to benefit from emerging trends across both API and CDMO domains through innovation and capex.
 "Divis Labs rallies 13% in 1 week; What's driving pharma stock?")
Lupin, Granules: Which pharma stocks to buy, sell amid US tariff flip-flop?
Technical charts show that select pharma stocks are trading with a negative bias and can tumble up to 19% from here. Granules India, however, looks strong on chart and can rally up to 19%.
 "Lupin, Granules: Which pharma stocks to buy, sell amid US tariff flip-flop?")
Tariff relief buzz lifts Nifty Pharma Index; Lupin, Aurobindo lead gains
Pharma stocks were rising in trade today as export concerns eased on US tariff report. Check out the top stocks that may benefit from US tariff relief
 "Tariff relief buzz lifts Nifty Pharma Index; Lupin, Aurobindo lead gains")
Lupin shares jump 4% on new Florida manufacturing facility plan
Lupin said the project aims to boost medicine security, diversify supply chains, and reinforce its position as a global leader in respiratory therapies
 "Lupin shares jump 4% on new Florida manufacturing facility plan")
Rubicon Research IPO opens Oct 9; key risks, strengths you must know
Rubicon Research IPO is available at a price band of ₹461-485 per share, with a lot size of 30 shares
 "Rubicon Research IPO opens Oct 9; key risks, strengths you must know")
Nifty Pharma down 2.5% as Trump slaps 100% import tariffs; impact decoded
Among individual counters, Sun Pharma slumped 4.87 per cent to a fresh 52-week low of ₹1,548, while Gland Pharma tumbled 4.70 per cent to ₹1,880. Biocon declined 3.68 per cent to ₹342.85.
 "Nifty Pharma down 2.5% as Trump slaps 100% import tariffs; impact decoded")
Asia stocks slide as Trump slaps new pharma tariffs, Fed cut bets recede
Shares of pharmaceutical companies across Asia tumbled in the aftermath, with Japan's Topix pharmaceutical index last down 1.2 per cent, while Hong Kong-listed innovative drug index fell 2 per cent
 "Asia stocks slide as Trump slaps new pharma tariffs, Fed cut bets recede")
Dr Reddy's, Sun: Pharma stocks can crash up to 30% on Trump's 100% tariff
Indian pharma shares - Dr.Reddy's, Cipla, Sun, Lupin and Aurobindo Pharma stare at up to 30 downside risk hint technical charts as US President Donald Trump announces 100% tariff on pharma imports.
 "Dr Reddy's, Sun: Pharma stocks can crash up to 30% on Trump's 100% tariff")
Stocks to Watch today, Sept 26: Pharma, IT, auto, Polycab, Rites, Eternal
Stocks to Watch today, September 26, 2025: From Pharma, auto to Polycab, here is a list of stocks that will be in focus
 "Stocks to Watch today, Sept 26: Pharma, IT, auto, Polycab, Rites, Eternal")
Why Nomura continues to back Glenmark Pharma; Retains 'Buy'; Find out here
Analysts at Nomura continue to back Glenmark Pharma, citing the company's ability to strategically acquire high-potential innovative products.
 "Why Nomura continues to back Glenmark Pharma; Retains 'Buy'; Find out here")
Sun Pharmaceutical: Domestic, innovation push eyed; Nuvama maintains 'Hold'
Sun Pharma aims to strengthen its domestic formulations business through field force expansion and a generic GLP-1 launch in CY26.
 "Sun Pharmaceutical: Domestic, innovation push eyed; Nuvama maintains 'Hold'")
Shilpa Medicare hits 5% upper circuit; here's what sparked the rally today
Around 1:30 PM, Shilpa Medicare shares continued to trade 2.04 per cent higher at ₹833.95 per share. In comparison, BSE Sensex was trading flat at 82,176.17 levels.
Natco Pharma surges 5% after USFDA classifies Hyderabad facility as VAI
Natco Pharma stock was trading at ₹884.5, up 3.2 per cent compared to the previous session's close of ₹857.25 on the NSE
 "Natco Pharma surges 5% after USFDA classifies Hyderabad facility as VAI")
Cohance Lifesciences shares slide 8% on block deals; Likely seller here
Cohance Lifesciences shares fell the most since August 14, after about 8.9 per cent stake changed hands on the NSE
 "Cohance Lifesciences shares slide 8% on block deals; Likely seller here")
Pharma in bitter health: Stocks sink upto 38% in 2025; time to bottom fish?
Among stocks, Natco Pharma plunged 37.85%, Ipca Labs 22.43%, Aurobindo Pharma 17.99%, and Sun Pharma 14.30%. Other laggards include Lupin (13.25%), and Dr Reddy's (5.17%).
 "Pharma in bitter health: Stocks sink upto 38% in 2025; time to bottom fish?")
Dr Reddy's shares fall as USFDA flags Hyderabad plant with 5 observations
Dr Reddy's shares fell on Monday after the USFDA issued a Form 483 with five observations at its Hyderabad plant inspection
 "Dr Reddy's shares fall as USFDA flags Hyderabad plant with 5 observations")
Blue Jet Healthcare down 4% as promoter launches OFS at ₹675; check details
Blue Jet Healthcare's share price was trading 3.55 per cent lower at ₹704.8 per share compared to previous day's close of ₹730 on the NSE
 "Blue Jet Healthcare down 4% as promoter launches OFS at ₹675; check details")
Laurus Labs gains 3%, nears record high; should you buy, hold or sell?
Thus far in September, the stock price of Laurus Labs has rallied 6 per cent, as compared to a 1.5 per cent rise in the BSE Sensex and BSE Healthcare index
 "Laurus Labs gains 3%, nears record high; should you buy, hold or sell?")
Glenmark Pharma up 3% on DCGI nod to start phase 3 trial of Envafolimab
Around 11:20 PM, Glenmark Pharmaceuticals shares continued to trade higher, up 3.05 per cent at ₹2,051.40 per share. In comparison, BSE Sensex was trading 0.25 per cent lower at 80,518.51 levels.